Edwards Lifesciences (EW) Invested Capital (2009 - 2018)

Edwards Lifesciences' (EW) quarterly Invested Capital came in at $598.6 million in Q1 2018, up 1057.83% quarter-over-quarter from $51.7 million in Q4 2017.

Edwards Lifesciences (EW) Invested Capital (2009 - 2018) Analysis & Trends

Edwards Lifesciences' Invested Capital history runs 6 years deep, the most recent figure standing at $598.6 million for Q1 2018.

  • On a quarterly basis, Invested Capital changed N/A year-over-year to $598.6 million in Q1 2018; TTM through Dec 2018 was $598.6 million, a 542.27% increase from a year earlier, with the FY2017 full-year figure at $51.7 million, changed N/A from the prior year.
  • Invested Capital climbed to $598.6 million in Q1 2018 per EW's latest filing, from $51.7 million in the prior quarter.
  • Across five years, Invested Capital topped out at $598.6 million in Q1 2018 and bottomed at $41.5 million in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 4.41 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 499.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 1.41 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 7.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 15.00 Mn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 118.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2018 598.60 Mn
Dec 31, 2017 51.70 Mn
Sep 30, 2017 41.50 Mn
Dec 31, 2012 189.30 Mn
Dec 31, 2011 150.40 Mn
Mar 31, 2011 149.50 Mn
Dec 31, 2010 41.80 Mn
Sep 30, 2010 100.60 Mn
Dec 31, 2009 11.40 Mn